---
figid: PMC153630__pq0830882006
figlink: /pmc/articles/PMC153630/figure/F6/
number: Figure 6
caption: Schematic illustration of distinct signaling pathways induced by rhTum and
  rhEndo. rhTum binds to αvβ3 integrin, whereas rhEndo binds to α5β1 integrin. Both
  rhEndo and rhTum inhibit phosphorylation of FAK (yellow). Downstream of FAK, rhTum
  inhibits the PI3-K/Akt/mTOR/4EBP1 pathway, resulting in inhibition of endothelial
  protein synthesis and proliferation. MAP kinase pathways are not affected by rhTum.
  In contrast, inhibition of FAK activation by rhEndo binding to α5β1 integrin leads
  to inhibition of ERK1/p38 MAP kinase pathways with no effect on PI3-K/Akt/mTOR/4EBP1
  pathways, resulting in inhibition of endothelial cell migration.
pmcid: PMC153630
papertitle: Human tumstatin and human endostatin exhibit distinct antiangiogenic activities
  mediated by αvβ3 and α5β1 integrins.
reftext: Akulapalli Sudhakar, et al. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4766-4771.
pmc_ranked_result_index: '18389'
pathway_score: 0.9701277
filename: pq0830882006.jpg
figtitle: Distinct signaling pathways induced by rhTum and rhEndo
year: '2003'
organisms: Homo sapiens
ndex: e26b4e48-dec8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC153630__pq0830882006.html
  '@type': Dataset
  description: Schematic illustration of distinct signaling pathways induced by rhTum
    and rhEndo. rhTum binds to αvβ3 integrin, whereas rhEndo binds to α5β1 integrin.
    Both rhEndo and rhTum inhibit phosphorylation of FAK (yellow). Downstream of FAK,
    rhTum inhibits the PI3-K/Akt/mTOR/4EBP1 pathway, resulting in inhibition of endothelial
    protein synthesis and proliferation. MAP kinase pathways are not affected by rhTum.
    In contrast, inhibition of FAK activation by rhEndo binding to α5β1 integrin leads
    to inhibition of ERK1/p38 MAP kinase pathways with no effect on PI3-K/Akt/mTOR/4EBP1
    pathways, resulting in inhibition of endothelial cell migration.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARAF
  - PIK3R3
  - PIK3CG
  - PIK3CD
  - PIK3R5
  - MAP2K1
  - RAF1
  - EIF4EBP1
  - PIK3R6
  - MAP2K2
  - NRAS
  - PTK2
  - MTOR
  - PIK3CA
  - PIK3CB
  - KRAS
  - PIK3R4
  - MAP3K1
  - AKT3
  - EIF4E
  - HRAS
  - BRAF
  - AKT2
  - AKT1
  - MAPK3
  - MAPK12
  - MAPK14
  - MAPK13
  - MAPK11
  - Tumstatin
  - Endostatin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEKK
  symbol: MEKK
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
chemicals:
- word: Tumstatin
  source: MESH
  identifier: C057112
- word: Endostatin
  source: MESH
  identifier: D043169
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
